Home Interna Therapeutics

Interna Therapeutics

In operation
-
Intracellular Drug Delivery Technology Developer
Basic
Enterprise Profile

Basic Information

Interna Therapeutics is an innovative biotechnology company focused on intracellular drug delivery, possessing fully self-developed research facilities across the entire industry chain. The company has established a universal technology platform for intercellular delivery of macromolecular drugs — the Molecular Nano Motor (MNM) technology — developing a unique delivery method capable of transporting DNA, RNA, proteins, peptides, and other macromolecular substances into the cytoplasm. Given the significant benefits of MNM technology, the company places particular emphasis on well-known infectious respiratory viruses such as SARS-CoV-2, influenza, and RSV, as well as chronic respiratory diseases, neurological disorders, and intracellular peptide-drug delivery.
Interna Therapeutics, Ltd.
Israel
15~50 people
--
infointerna@interna.bio

Enterprise Profile

Industrial Sector
New Drug Development Drug Trial
Technology
Genetic Engineering Targeted Technology Nucleic Acid Technology Protein Technology
Concept
# Nervous System Diseases Respiratory Diseases Chronic Disease
Application Scenarios
New Product New Technology Innovative Drugs Biological Products